Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 8
Submit an article Journal homepage
901
Views
0
CrossRef citations to date
0
Altmetric
Editorial

From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition

Daniel Wendlinga Service de Rhumatologie, CHRU de Besançon; EA 4266, Université de Franche-Comté, Besançon, FranceCorrespondence[email protected]
View further author information
&
Philippe Goupilleb Service de Rhumatologie, CHRU de Tours; EA 7501, GICC, Université de Tours, Tours, FranceView further author information
Pages 837-840 | Received 24 Apr 2020, Accepted 10 Jun 2020, Published online: 17 Jun 2020

References

  • Wendling D, Claudepierre P, Prati C, et al. Spondyloarthritis: A concept or a disease? Joint Bone Spine. 2015 Dec;82(6):387–389.
  • Claudepierre P, Wendling D, Breban M, et al. Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: what’s in a name? Joint Bone Spine. 2012 Dec;79(6):534–535.
  • Prati C, Claudepierre P, Goupille P, et al. TNFα antagonist therapy in axial spondyloarthritis: can we do better? Joint Bone Spine. 2016 May;83(3):247–249.
  • Wendling D, Verhoeven F, Prati C. Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis. Expert Opin Biol Ther. 2019 Jan;19(1):55–64..
  • Wendling D, Prati C. Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis. Immunotherapy. 2017 Mar 9;9(3):221–223.
  • Chimenti MS, Fonti GL, Conigliaro P, et al. One-year effectiveness, retention rate and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study. DOI: 10.1080/14712598.2020.1761957.
  • Flachaire B, JG L, Labadie C, et al. Predictors of survival of secukinumab treatment in a multicenter cohort of 556 spondylarthritis (Abstract Number: 0934). Arthritis Rheumatol. 2019;71(S10):1622–1624.
  • Michelsen B, Askling J, Codreanu C, et al. 6 and 12-month drug retention rates and treatment outcomes in 941 patients with axial spondyloarthritis treated with secukinumab in routine clinical practice in 12 European countries in the EuroSpA research collaboration network (Abstract number: 1822). Arthritis Rheumatol. 2019;71(S10):3245–3248.
  • Braun J, Deodhar A, Landewé R, et al. Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies. RMD Open. 2018 Nov 21;4(2):e000749.
  • Maneiro JR, Souto A, Salgado E, et al. Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis. RMD Open. 2015;1:e000017.
  • Wendling D, Prati C. Smoking and spondyloarthritis: a bad connection. Rheumatol Int. 2015 Dec;35(12):1951–1953.
  • Micheroli R, Hebeisen M, LM W, et al. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis Res Ther. 2017;19(1):164.
  • Wendling D, Lukas C, Prati C, et al. 2018 update of French society for rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. Joint Bone Spine. 2018 May;85(3):275–284..
  • Wendling D, Prati C, Chouk M, et al. Effects of anti-IL-23 and anti-IL-17: the hidden side of spondyloarthritis polymorphism? Joint Bone Spine. 2020 Jan;87(1):5–7.
  • Lequerré T, Rottenberg P, Derambure C, et al. Predictors of treatment response in rheumatoid arthritis. Joint Bone Spine. 2019 Mar;86(2):151–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.